Cold Pain Therapy Market Research Report - Global Forecast till 2027

Cold Pain Therapy Market Research Report, by Product (Gels, Sprays, Patches), Therapy (Icepack Therapy and Chamber Therapy), Application (Musculoskeletal Disorders), End-User (Hospitals and Clinics and Sports person) – Forecast Till 2027

ID: MRFR/Pharma/5421-HCR | February 2021 | Region: Global | 90 pages         

Cold pain therapy market

The global cold pain therapy market size is projected to reach USD 2.3 billion at a CAGR of 4.7% during the forecast period of 2022-2030

Segmentation

By Product Gels Sprays Patches
By Therapy Icepack Therapy and Chamber Therapy
By Application Musculoskeletal Disorders
By End-User Hospitals and Clinics and Sports person

Key Players

  • Sanofi (France)
  • DJO Global (US)
  • Pfizer (US)
  • Hisamitsu Pharmaceutical (Japan)
  • Johnson & Johnson (US)
  • Medline Industries (US)
  • Össur (Iceland)
  • Performance Health (US)
  • Beiersdorf (Germany)
  • Rohto Pharmaceutical (US)

Drivers

  • Increasing prevalence of musculoskeletal injury and technological advancements in medical devices.
Speak to Analyst Request a Free Sample

Cold Pain Therapy Market Overview


According to the latest research report, The Cold Pain Therapy Market size was valued at USD 1.62 billion in 2017 and is predicted to grow at a compound annual growth rate of a CAGR of 4.6 percent to hit USD 2.12 billion by the end of the year 2023, representing a market size of USD 2.12 billion. Cold Pain Therapy, also known as cryotherapy, is a kind of treatment used to decrease swelling and pain that has been the source of pain. 


The usage of cold pain treatment also has the additional benefit of temporarily decreasing nerve signals, which lessens pain. The growing number of injuries sustained while participating in athletics and gym exercises, as well as the expanding health care costs related to injuries sustained while participating in sports exercise, are the primary drivers driving the expansion of the cold pain therapy market outlook. Market expansion, nevertheless, may be limited by issues such as a shortage of remuneration, a shortage of clinical indications for the drug for cold pain treatment, as well as the misery related to the treatment, among others.


This report contains all the information on the global Cold Pain Therapy Market analysis and its strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other essential factors. And a detailed analysis of the Cold Pain Therapy Market forecast for 2027 is also included in the report.


 Covid 19 Analysis of Cold Pain Therapy Market


The COVID-19 outbreak has hampered the cold pain therapy market growth. Due to the outbreak, accessibility to hospitals and commercial pharmacists was severely restricted, and orthopedic hospitals and rehab facilities were effectively suspended. Hospitalizations in the US fell by 30–60% after the countrywide lockdown was announced. The immediate suspension of gyms and fitness facilities, limits on outdoor physical endeavours, and social distancing procedures reduced the amount of stress and sports accidents. This further lowered cold pain treatment sales. This industry is likely to increase rapidly in the next months when health care facilities, pharmacies, and sports facilities reopen and lockdown restrictions are relaxed.


Cold Pain Therapy Market Dynamic                  


Drivers


Sports-related injuries involving the musculoskeletal system are the most prevalent. Tennis elbow, Ankle sprains, joint injuries, knee injuries, fractures, and dislocations are just a few of the more prevalent ailments that occur. Because they give immediate pain medication, cold pain therapy goods, including cold packs and mists, are most widely utilized to treat sports-related wounds. As a result of rising disposable income, increasing health awareness, increasing obesity rates, and increasing stress levels, individuals worldwide are placing more importance on gym routines and exercises.


Opportunities


Compared to standard parenteral or oral medication administration methods, patches are simple, non-invasive, painless, and convenient. They also improve patient adherence and offer site-specific dosage. Patches release an analgesic medication across the dermis when applied to the skin. Analgesic patches delivered transdermally have many benefits over oral medicines.


Restraints


Price-sensitive consumers in developing markets choose lower-cost goods. Analgesics including ibuprofen, paracetamol, and aspirin are some of the most often used OTC medications, and these medications are inexpensive. This, together with a lack of knowledge about the risks of painkillers, contributes to the widespread use of analgesics for rapid pain control.


The increased consumption of OTC pharmaceuticals by consumers in developing countries due to low-cost generic drugs, lack of understanding about novel pain management techniques, and rising medical problems limit market expansion.


Challenges


Patients often use alternative treatments options to alleviate symptoms of pain. Thus, patients' increased choice of alternative medicines may provide a key market growth barrier.


Cumulative Growth Analysis


The over-the-counter (OTC) product sector now controls the bulk of the market share due to its widespread availability and the emergence of e-commerce around the globe. Furthermore, the increasing frequency of musculoskeletal problems, as well as developments in product innovations that provide immediate pain relief, are propelling the segment's expansion forward. The availability of a diverse variety of goods, such as gels, patched skin, ice pack, roll-ons, and mists, is also projected to contribute to developing the OTC product category throughout the forecast period. For example, in March 2019, Performance Health announced the introduction of the Biofreeze pain treatment patch, which has since become a popular product.


Value Chain Analysis


According to the reports, the market is categorized further based on the product, Application, treatment, and end-user. The Cold Pain Therapy Market is classified into two types of goods: prescription products and over-the-counter (OTC) products. A subset of over-the-counter (OTC) items is divided into lotions and mists; a subset of prescription products are divided into motorized and non-motorized devices. A subset of OTC products is divided into gels and sprays. The market is categorized based on Application into four categories: musculoskeletal diseases, sports medicine, post-operative treatment, and post-trauma therapy. The market is split into three categories based on the kind of treatment used: chamber therapy, icepack therapy, and cryosurgery. Market segments are based on end-user, with hospitals and clinics being the most common. Other segments include adults, athletes, and others.


Segmentation Overview


The market is segmented on the product, Application, treatment, end-user, and regions. The global Cold Pain Therapy Market trend is expected to witness decent growth during the forecast period.


By Application             


The Application is segmented into musculoskeletal diseases, sports medicine, post-operative treatment, and post-trauma therapy.


By end-users


The market is segmented into hospitals and clinics, being the most common. Other segments include adults, athletes, and others.


Regional Analysis


According to the reports, Cold Pain Therapy Market is divided into the Americas, Europe, Asia-Pacific, Middle East, and Africa. North America is expected to lead the global cold pain therapy market share because of a rise in healthcare expenditure, an increase in sports-related accidents, and a rising focus on gym exercises to preserve fitness. According to the National Safety Council (NSC), sports activities produced the most injuries in 2015, with basketball accounting for 493,011 cases, second by bike with 488,123 cases, and 399,873 cases. Many sports-related injuries may lead to an upsurge in need for global cold pain treatment.


Due to the rising government influence of pain drugs, increased car accidents caused by driving while intoxicated, and increased back pain, Europe was the 2nd largest market for cold pain treatment. Opioid-based pain relievers are often found in most over-the-counter medications. Cold pain therapy is preferred by people who do not want to deal with the adverse reactions and responses that drugs might produce. The long-term utilization of painkillers may contribute to the development of dependence or the development of an addiction.


Competitive landscape


The cold pain therapy market value is somewhat fragmented, with more market participants than in the previous market. There are well-established industry companies that are gaining traction by embracing e-commerce and extending their operations into new geographic areas. Furthermore, the cold pain therapy market is seeing the entrance of new industry players and the debut of new products, all of which are expected to make a significant contribution to market development.


Major Key Players



  • Sanofi (France),

  • DJO Global (US),

  • Pfizer (US),

  • Hisamitsu Pharmaceutical (Japan),

  • Johnson & Johnson (US),

  • Medline Industries (US),

  • Össur (Iceland), Performance Health (US),

  • Beiersdorf (Germany),

  • Rohto Pharmaceutical (US),

  • Breg (US),

  • Romsons Group of Industries (India) and Others.


Report Overview


The following report comprises of –



  • Market overview 

  • Covid 19 Analysis

  • Market Dynamic

  • Drivers

  • Opportunities

  • Restraints 

  • Challenges

  • Cumulative Growth Analysis

  • Value Chain Analysis

  • Segmentation Overview 

  • By Application 

  • By End-Users

  • Regional Analysis

  • Competitive landscape


Recent Developments



  • Cold Patches Biofreeze Pain Relief Patch was introduced by Performance Health in 2019.

  • Earlier this year, DJO Global debuted the DonJoy IceMan CLASSIC3 cooling pads.

  • A strategic relationship between Japanese pharmaceutical company Hisamitsu and the Tokyo 2020 Olympic and Paralympic Games was announced in 2018. Hisamitsu expanded its brand's visibility by becoming an official partner in the delivery of athelete-specific external pain treatment goods.


Global Cold Pain Therapy Market, by Product: Over the Counter Products:



  • Gels

  • Sprays

  • Patches

  • Cold Packs

  • Wraps

  • Pads

  • Roll-Ons


Prescription Products



  • Motorized

  • Non-Motorized Devices


Global Cold Pain Therapy Market, by Therapy:



  • Icepack Therapy

  • Chamber Therapy

  • Cryosurgery


Global Cold Pain Therapy Market, by Application:



  • Musculoskeletal Disorders

  • Post-Operative Therapy

  • Sports Medicine

  • Post-Trauma Therapy


Global Cold Pain Therapy Market, by End-Users:



  • Hospitals and Clinics

  • Sports Person

  • Adults

  • Others


Global Cold Pain Therapy Market, by Region:



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

During the projection period of 2021-2031, demand for over-the-counter (OTC) goods such as lotions, creams, patches, and the like is expected to be strong.

At the moment, North America is the fastest-growing market for cold pain treatment, and it is likely to take over as the leader in the near future.

It is nevertheless difficult to avoid the use of pain relievers and discomfort when undergoing cold pain treatment.

During the projection period of 2021-2031, demand for over-the-counter (OTC) goods such as lotions, creams, patches, and the like is expected to be strong.

At the moment, North America is the fastest-growing market for cold pain treatment, and it is likely to take over as the leader in the near future.

It is nevertheless difficult to avoid the use of pain relievers and discomfort when undergoing cold pain treatment.